Review

Risk and Resilience: The Role of Brain-derived Neurotrophic Factor in Alcohol Use Disorder

  • Received: 19 September 2016 Accepted: 26 October 2016 Published: 29 October 2016
  • Brain-derived neurotrophic factor (BDNF) is well known for its role in synaptic plasticity. More recently, BDNF has come to be regarded as a potential resilience factor in a variety of conditions that are characterized by maladaptive neuroplasticity, including alcohol use disorder. Research in animal models suggests that BDNF may serve as a protective gatekeeper in the transition from social drinking to compulsive alcohol consumption. Further, stress-induced modification of BDNF signaling may have an important role in anxiety-modulated alcohol consumption. In this article, we will review recent studies of BDNF and alcohol use in human participants. Studies included in this review have used genetic or epigenetic approaches or have measured peripheral BDNF protein levels in serum or plasma. Importantly, a number of these studies have incorporated neuroimaging methods to provide information about structural and/or functional central nervous system correlates of BDNF measures in relation to alcohol use. While there remains a great deal of variability in research findings from human participants on this issue, a number of studies suggest that behavioral or pharmacological interventions designed to enhance neuroplasticity may be a promising avenue for future research on alcohol use disorder.

    Citation: Natalie Ceballos, Shobhit Sharma. Risk and Resilience: The Role of Brain-derived Neurotrophic Factor in Alcohol Use Disorder[J]. AIMS Neuroscience, 2016, 3(4): 398-432. doi: 10.3934/Neuroscience.2016.4.398

    Related Papers:

    [1] Luana Muniz de Oliveira, Ágda Malany Forte de Oliveira, Railene Hérica Carlos Rocha Araújo, George Alves Dias, Albert Einstein Mathias de Medeiros Teodósio, José Franciraldo de Lima, Luana da Silva Barbosa, Wellinghton Alves Guedes . Spirulina platensis coating for the conservation of pomegranate. AIMS Agriculture and Food, 2020, 5(1): 76-85. doi: 10.3934/agrfood.2020.1.76
    [2] Hesti Kurniasari, Wahyudi David, Laras Cempaka, Ardiansyah . Effects of drying techniques on bioactivity of ginger (Zingiber officinale): A meta-analysis investigation. AIMS Agriculture and Food, 2022, 7(2): 197-211. doi: 10.3934/agrfood.2022013
    [3] Ilaria Marotti, Francesca Truzzi, Camilla Tibaldi, Lorenzo Negri, Giovanni Dinelli . Evaluation of licorice (Glycyrrhiza glabra L.) as a novel microgreen from the anti-inflammatory potential of polyphenols. AIMS Agriculture and Food, 2021, 6(1): 1-13. doi: 10.3934/agrfood.2021001
    [4] Teti Estiasih, Jatmiko Eko Witoyo, Khofifah Putri Wulandari, Fadhillah Dwi Juniati, Widiastuti Setyaningsih, Hanifah Nuryani Lioe, Miguel Palma, Kgs Ahmadi, Hamidie Ronald Daniel Ray, Elya Mufidah . Stability comparison of conventional and foam-mat red and purple dried roselle calyces powder as a function of pH. AIMS Agriculture and Food, 2025, 10(1): 177-198. doi: 10.3934/agrfood.2025010
    [5] Stefano Puccio, Anna Perrone, Giuseppe Sortino, Giuseppe Gianguzzi, Carla Gentile, Vittorio Farina . Yield, pomological characteristics, bioactive compounds and antioxidant activity of Annona cherimola Mill. grown in mediterranean climate. AIMS Agriculture and Food, 2019, 4(3): 592-603. doi: 10.3934/agrfood.2019.3.592
    [6] Rosalía García-Vásquez, Araceli Minerva Vera-Guzmán, José Cruz Carrillo-Rodríguez, Mónica Lilian Pérez-Ochoa, Elia Nora Aquino-Bolaños, Jimena Esther Alba-Jiménez, José Luis Chávez-Servia . Bioactive and nutritional compounds in fruits of pepper (Capsicum annuum L.) landraces conserved among indigenous communities from Mexico. AIMS Agriculture and Food, 2023, 8(3): 832-850. doi: 10.3934/agrfood.2023044
    [7] Katarzyna Gościnna, Elżbieta Wszelaczyńska, Jarosław Pobereżny . Potential of a new beetroot cultivar ‘Śnieżna kula’ (Beta vulgaris L. ssp.). AIMS Agriculture and Food, 2020, 5(4): 563-577. doi: 10.3934/agrfood.2020.4.563
    [8] Cíntia Sorane Good Kitzberger, Maria Brígida dos Santos Scholz, Luiz Filipe Protasio Pereira, João Batista Gonçalves Dias da Silva, Marta de Toledo Benassi . Profile of the diterpenes, lipid and protein content of different coffee cultivars of three consecutive harvests. AIMS Agriculture and Food, 2016, 1(3): 254-264. doi: 10.3934/agrfood.2016.3.254
    [9] Gad G. Yousef, Allan F. Brown, Ivette Guzman, James R. Ballington, Mary A. Lila . Variations in chlorogenic acid levels in an expanded gene pool of blueberries. AIMS Agriculture and Food, 2016, 1(3): 357-368. doi: 10.3934/agrfood.2016.3.357
    [10] Francyelli Regina Costa-Becheleni, Enrique Troyo-Diéguez, Alan Amado Ruiz-Hernández, Fernando Ayala-Niño, Luis Alejandro Bustamante-Salazar, Alfonso Medel-Narváez, Raúl Octavio Martínez-Rincón, Rosario Maribel Robles-Sánchez . Determination of bioactive compounds and antioxidant capacity of the halophytes Suaeda edulis and Suaeda esteroa (Chenopodiaceae): An option as novel healthy agro-foods. AIMS Agriculture and Food, 2024, 9(3): 716-742. doi: 10.3934/agrfood.2024039
  • Brain-derived neurotrophic factor (BDNF) is well known for its role in synaptic plasticity. More recently, BDNF has come to be regarded as a potential resilience factor in a variety of conditions that are characterized by maladaptive neuroplasticity, including alcohol use disorder. Research in animal models suggests that BDNF may serve as a protective gatekeeper in the transition from social drinking to compulsive alcohol consumption. Further, stress-induced modification of BDNF signaling may have an important role in anxiety-modulated alcohol consumption. In this article, we will review recent studies of BDNF and alcohol use in human participants. Studies included in this review have used genetic or epigenetic approaches or have measured peripheral BDNF protein levels in serum or plasma. Importantly, a number of these studies have incorporated neuroimaging methods to provide information about structural and/or functional central nervous system correlates of BDNF measures in relation to alcohol use. While there remains a great deal of variability in research findings from human participants on this issue, a number of studies suggest that behavioral or pharmacological interventions designed to enhance neuroplasticity may be a promising avenue for future research on alcohol use disorder.


    Abbreviations: GAE/g: Gallic acid equivalents per one gram; CE/g: Catechin equivalents (CE) per one gram; RE/g: Rutin equivalents per one gram; QuE: Quercetin equivalent

    Pomegranate is native to Persia and Mediterranean zone and has been widely used in many countries and cultures [1]. Pomegranate has attracted considerable attention for its health benefits in recent years. Results show that pomegranate juice has markedly high total phenolic contents and antioxidant capacity, being responsible for beneficial activities of pomegranates. Total phenolic content plays a probable role in preventing different diseases related to oxidative stress such as cardiovascular [2,3,4], cancer [5,6] and neurodegenerative diseases [7,8]. Pomegranate juice has excellent antioxidant activity and is beneficial for atherosclerosis prevention [2,3,4], In this regard, polyphenols are capable of moderating the broad range of enzymes activities and cell receptors [9]. The main part of pomegranate seed oil is Punicic acid having anti-atherogenic effects [10].

    Pomegranate extract has potential to decrease the incidence of collagen-induced arthritis. In an in-vivo study into mice fed by pomegranate extract, it was indicated that joint inflammation, arthritis severity and IL-6 level were decreased remarkably [11]. Pomegranate has been widely accepted for its antimicrobial [12,13,14], and anti-candidial activities by in-vitro [15] and iv-vivo investigations [16]. Crude extract of pomegranate peel yielded a compound that demonstrated potent antifungal activity to Candida spp. [13]. The compound was recognized as punicalagin, based on spectral analyses [17]. Punicalagin showed high activity against Candida albicans and Candida parapsilosis, as tested by minimum inhibitory concentration (MIC) [14]. Pomegranate pericarp and peel extracts are reported to possess strong activity against Candida spp., with MICs of 125 μg/mL [18]. Salazar Aranda et al. [19] showed that polyphenolics compound had antioxidant activity, and they revealed its highest activity against C. glabrata by MIC test. The effect of their hydroxyl groups on their activity against C. glabrata is considerable. Furthermore, it has been shown that pomegranate peel has a high inhibition capacity against C. albicans [19,20]. Bassiri-Jahromi et al. in their in-vitro [15] and in-vivo [16] investigations indicated that pomegranate peel extract had potential antifungal activity against 5 various Candida species. This investigation demonstrated that among 8 different Persian pomegranate cultivars, Saveh sour malas peel extract indicated strongest antifungal activity against C.albicans, which was comparable to nystatin. Bassiri-Jahromi et al. reported that pomegranate peel extract had no adverse effects following application in the rats' model. Pomegranate peel extract application was effective and safe in treating oral candidiasis in the Wistar rats [21].

    Schubert et al. (1999) in their studies clearly demonstrated that pomegranate fermented juice and seed procurement and pomegranate seed oil contained powerful antioxidant properties [22]. Therefore, pomegranate can play a potential role as natural food preservative, health promotion and therapeutic agents.

    This paper provides a general review of the evaluation of polyphenolic and flavonoid contents of various pomegranate cultivars in different regions of the world.

    Pomegranate has considerable content of phytochemicals compounds such as punicalagin, ellagitannins, anthocyanins, tannins, hydrolysable tannins, and punicic acid [18,19,20,21,22,23]. Pomegranate peel is a valuable source of polyphenolic compounds, known as punicalagin, which is an ellagitannin with antioxidant capacity and is unrivaled and unique to pomegranate [24].

    Phenolic compounds have attracted increasing attention as agents for inhibiting and treating various oxidative stress correlated diseases, preventing conventional and novel biomarkers of tissue plasminogen activator (TPA) induced tumor promotion, as well as possessing chemo-preventive role in various tumor models [25]. These compounds are recognized for their attributes in scavenging free radicals and preventing in-vitro lipid oxidation [26,27].

    Polyphenol is a significant antioxidant found in pomegranate seed and juice containing ellagitannin (punicalagin), gallic acid, ellagic acid, anthocyanins, catechins, caffeic acid, and quercetin [28]. Flavonoids may prevent coronary artery diseases by inducing various processes such as HDL increase, LDL decrease level, mast cell release reduction, and cardiovascular inflammation decrease. Flavonoids have been recognized with antiviral activity since the 1940s [29]. Selway et al. (1986) have reported that flavonoids contain antiviral activity against 11 types of viruses [30]. Furthermore, flavonoids possess protective effect against liver injury [31]. There is incisive documentary evidence that flavonoids have anti-mutagenic acting [32,33].

    Pomegranate peel is a significant source of bioactive compounds such as flavonoids, polyphenols, ellagitannins, and proanthocyanidin [34]; however, this part of the fruit is inedible. The antibacterial activity of peel extracts of Indian Ganesh variety was tested by Malviya et al. using the agar well diffusion method against four bacterial strains, Staphylococcus aureus, Salmonella typhi, Enterobacter aerogenes, and Klebsiella pneumoniae. The pomegranate peel extracts showed significant antibacterial activities against all of the 4 bacterial strains tested [35].

    The abundance of these compounds and their activities are related to cultivar type, climate, and growing region [36,37]. Up to now, polyphenols of different pomegranate cultivars in Iran [38], Turkey [39], the United States [40], Italy [41] and South Africa have been investigated [42]. Fawole et al. showed that the highest peel extract activity against monophenolase activity and phenolase activity was Bhagwa cultivar and Arakta cultivar with IC50 values of 3.66 μg/mL and 15.88 μg/mL, respectively [43].

    Almost 50% of the pomegranate weight corresponds to the peel [44]. Total polyphenols, flavonoids and pro-athocyanidins contents are superior in pomegranate peel extract than in pomegranate pulp extract owing to their powerful antioxidant capacity [45].

    According to Shams Ardekani et al. (2011) [38] report from Iran, sour summer cultivar peel extract has the highest antioxidant activity with 118.074 mg or 274.132 μ mol trolox/g. Sour summer cultivar is a strong source of natural antioxidants, phenolic and flavonoid content and the peel of Sweet Saveh malas, Sour summer and Black peel cultivars are suitable sources of phenolic and flavonoid compounds.

    This review will investigate the evidence for the identity of the antioxidant content of various cultivars of pomegranate such as polyphenols and flavonoids, playing a probable role in preventing different diseases associated with oxidative stress such as cardiovascular, cancer and neurodegenerative diseases.

    The results provide significant information about the compound of polyphenols and antioxidant content of different cultivars of pomegranate, which can be useful for expanding fruit processing professions and choosing favorable pomegranate genotypes to provide commercial agriculture.

    The phenolic and flavonoids content are different; the antioxidant activity of various solvent extracts from pomegranate peel was also surveyed using in vitro assays.

    Gil et al. (2000) [27] evaluated antioxidant acting of pomegranate by four comparative assays: ABTS, DPPH, DMPD, FRAP, and they were detected and quantified using ellagic acid anthocyanins, and hydrolyzable tannins in pomegranate juice. They reported that the antioxidant capacity of commercial pomegranate juice was three times superior to red wine and green tea.

    Pomegranate peels have significant superior antioxidant potency compared to other parts of pomegranate against free radical activities. It also contains higher total polyphenols, flavonoids and pro-athocyanidins than pulp extract. Strong antioxidant potency of pomegranate peel extract may be due to its major polyphenolics contained [46]. In the present study, various cultivars from different regions were described evaluate the phenolic and flavonoid contents. Tables 1, 2 and 3 present the obtained data.

    Table 1.  Comparative evaluation of polyphenolic and flavonoid content of peels of various pomegranate (Punica granatum) cultivars from different regions in the world.
    No. Author/References Cultivar Region of growth (Country) Fruit part Total Polyphenolic Compound mg GAE/g extract Flavonoids (mg/g), Total flavonoids mg CE/g extract
    1 Fawole OA et al. (2012) [67] Ganesh South Africa Peel 295.5 ± 23.91 d mg GAE/ g DM 121.1 ± 3.12 c mg CAE/g DM
    2 Shiban MS et al. (2012) [68] Yemeni variety Yemen Peel 274.1 ± 17.2 mg GAE/g 56.4 ± 2.7 c mg (RE)/g.
    3 Ardekani MRS et al. (2011) [38] Black peel Iran Peel 250.13 ± 33.03 mg GAE/g 36.40 ± 1.34 mg CAE/g DM
    4 Kulkarni AP et al. (2004) [58] Kashmir India Peel 249.4 mg GAE/g 59.4 mg CE/g dry solids
    5 Li Y et al. (2006) [45] China China Peel 249.4 ± 17.2 mg/g 59.1 ± 4.8 (mg/g)
    6 Ardekani MRS et al. (2011) [38] Sour Summer Iran Peel 226.56 ± 18.98 mg GAE/g 35.92 ± 0.84 mg CAE/g DM
    7 Fawole OA et al. (2012) [67] Bhagwa South Africa Peel 224.1 ± 6.86 c mg GAE/g DM 112.6 ± 1.51 b mg CAEg DM
    8 Fawole OA et al. (2012) [67] Ruby South Africa Peel 218.2 ± 4.53 bc mg GAE/g DM 126.0 ± 0.57 c mg CAE/g DM
    9 Ardekani MRS et al. (2011) [38] Saveh sour malas Iran Peel 216.74 ± 19.01 mg GAE/g 34.71 ± 1.34 mg CAE/g DM
    10 Nasr CB et al. (1996) [69] Tunesia Tunesia Peel 216.9 ± 7.3 mg GAE/g
    11 Mphahlelea RR et al. (2016) [66] South Africa South Africa peel 215.21 ± 21.90 b 36.67 ± 3.43 ab
    12 Mphahlelea RR et al. (2016) [66] South Africa South Africa Peel & seed 138.36 ± 2.27 c 50.39 ± 6.93 a
    13 Mphahlelea RR et al. (2016) [66] South Africa South Africa Whole fruit 185.73 ± 3.89 b 23.35 ± 2.07 b
    14 Fawole OA et al. (2012) [67] Herskawitz South Africa Peel 198.1 ± 9.22 abc mg GAE/g DM 101.0 ± 1.02a mg CAE/g DM
    15 Ardekani MRS et al. (2011) [38] North white peel Iran Peel 192.72 ± 15.45 mg GAE/g 26.94 ± 0.48 mg CAE/g DM
    No. Author/References Cultivar Region of growth (Country) Fruit part Total Polyphenolic Compound mg GAE/g extract Flavonoids (mg/g), Total flavonoids mg CE/g extract
    16 Fawole OA et al. (2012) [67] Wonderful South Africa Peel 189.1 ± 3.79 ab mg GAE/g 97.8±2.10a mg GAE/g DM
    17 Fawole OA et al. (2012) [67] Arakta South Africa Peel 187.4 ± 6.44ab mg GAE/g DM 103.0 ± 1.86a mg CAE/g DM
    18 Rosas-Burgos EC (2017) [56] Cultivar (PTO8) Spain Peel 187 ± 4 mg GAE/g
    19 Ardekani MRS et al. (2011) [38] Sweet alac Iran Peel 184.10 ± 25.07 mg GAE/g 30.36 ± 2.44 mg CAE/g DM
    20 Fawole OA et al. (2012) [67] Molla de Elche South Africa Peel 179.3 ± 4.60a mg GAE/g DM 99.5 ± 2.94a mg CAE/g DM
    21 Ardekani MRS et al. (2011) [38] Agha mohammad ali Iran Peel 168.21 ± 13.9 mg GAE/g 33.52 ± 0.41 mg CAE/g DM
    22 Belkacem N et al. (2014) [70] Algerian pomegranate Algeria Peel 158.18 ± 0.66 mg GAE/g DM 12.8 ± 2.2 mg CE/g
    23 Negi P et al. (2003) [71] Pomegranate varieties from India India Peel 124.3 mg GAE/g 49.1 mg CE/g dry solids
    24 Ardekani MRS et al. (2011) [38] Sweet malas Iran Peel 121.11 ± 8.69 mg GAE/g 18.61 ± 0.53 mg CAE/g DM
    25 Ardekani MRS et al. (2011) [38] Sour white peel Iran Peel 98.24 ± 4.81 mg GAE/g 28.30 ± 0.54 mg CAE/g DM
    26 Al-Rawahi AS et.al. (2014) [72] Hellow Oman Peel 64.2 mg GAE/g 1.4 mg CE/g
    27 Dipnaik HS et al. (2014) [73] Indian pomegranate India Peel 59.73 ± 0.46 mg GAE/gm
    28 Gozlekci S et al. (2011) [74] Lefan Turkish Peel 3547.8a µg GAE/g fw
    31 Gozlekci S et al. (2011) [74] Katirbasi Turkish Peel 3127.0b µg GAE/g
    34 Gozlekci S et al. (2011) [74] Cekirdeksiz-Ⅳ Turkish Peel 2537.1c µg GAE/g fw. GAE/g fw
    35 Gozlekci S et al. (2011) [74] Asinar Turkish Peel 17.75.4d GAE/g fw
    36 Souleman AMA et al. (2016) [59] PG1 Egypt Peel 172.4 ± 1.11c (GAE mg/g FW) 34.28 ± 1.47 (REmg/g FW)
    37 Souleman AMA et al. (2016) [59] PG2 Egypt Peel 135.8 ± 0.92 (GAE mg/g FW) 29.65 ± 0.59a (REmg/g FW)
    38 Souleman AMA et al. (2016) [59] PG3 Egypt Peel 98.6 ± 1.13a (GAE mg/g FW) 21.72 ± 0.38 (REmg/g FW)
    39 Souleman AMA et al. (2016) [59] PG4 Egypt Peel 102.9 ± 1.28 30.29 ± 1.29a (REmg/g FW)
    40 Souleman AMA et al. (2016) [59] PG5 Egypt Peel 95.8 ± 1.19a (GAE mg/g FW) 26.35 ± 1.16 (REmg/g FW)

     | Show Table
    DownLoad: CSV
    Table 2.  Comparative evaluation of polyphenolic and flavonoid content of juicees of various pomegranate (Punica granatum) cultivars from different regions.
    No. Author/References Cultivar Region of growth (Country) Total Polyphenolic Compound mg GAE/g extract Flavonoids (mg/g), Total flavonoids mg CE/g extract
    1 Gozlekci S et al. (2011) [74] Lefan Turkish 1551.5 µg GAE/g fw
    2 Gozlekci S et al. (2011) [74] Katirbasi Turkish 1229.5 mg/L µg GAE/g fw
    3 Gozlekci S et al. (2011) [74] Asinar Turkish 1307.3 µg GAE/g fw
    4 Nunzio MD et al. (2013) [75] Hershkovitz Italian 2057.2 ± 174.0a μg GAmL−1)
    5 Li X et al. (2015) [76] XJ-TSL China 4.352 ± 0.09 de d (GaE mg/mL) 0.118 ± 0.00 d QuE mg/mL
    6 Li X et al. (2015) [76] XJ-SSL China 6.147 ± 0.11 b (GaE mg/mL) 0.045 ± 0.01 h QuE mg/mL
    7 Li X et al. (2015) [76] SD-TSL China 7.429 ± 0.12 a (GaE mg/mL) 0.335 ± 0.13 a QuE mg/mL
    8 Li X et al. (2015) [76] SD-SSL China 4.481 ± 0.11 d (GaE mg/mL) 0.093 ± 0.00 e QuE mg/mL
    9 Li X et al. (2015) [76] YN-SZ China 3.234 ± 0.06 g (GaE mg/mL) 0.099 ± 0.00 e QuE mg/mL
    10 Li X et al. (2015) [76] YN-LZ China 3.151 ± 0.05 g(GaE mg/mL) 0.084 ± 0.00 f QuE mg/mL
    11 Li X et al. (2015) [76] YN-SSL China 4.142 ± 0.08 f (GaE mg/mL) 0.171 ± 0.00 c QuE mg/mL
    12 Li X et al. (2015) [76] SX-JPT China 4.219 ± 0.10 ef (GaE mg/mL) 0.259 ± 0.00 b QuE mg/mL
    13 Li X et al. (2015) [76] SX-SBT China 4.750 ± 0.08 c (GaE mg/mL) 0.170 ± 0.00 c QuE mg/mL
    14 Li X et al. (2015) [76] SX-SSL China 4.735 ± 0.03 c (GaE mg/mL) 0.054 ± 0.00 g QuE mg/mL
    15 Li X et al. (2015) [76] SD-TSL China 7.429 ± 0.12 a (GaE mg/mL) 0.335 ± 0.13 a QuE mg/mL
    16 Souleman AMA et al. (2016) [59] PG1 Egypt 72.4 ± 0.22 (GAE mg/g FW) 12.31 ± 0.91a (REmg/g FW)
    17 Souleman AMA et al. (2016) [59] PG2 Egypt 63.7 ± 1.16a (GAE mg/g FW) 9.64 ± 0.25 (REmg/g FW)
    18 Souleman AMA et al. (2016) [59] PG3 Egypt 64.3 ± 0.29a (GAE mg/g FW) 10.38 ± 1.34b (REmg/g FW)
    19 Souleman AMA et al. (2016) [59] PG4 Egypt 52.1 ± 0.18b (GAE mg/g FW) 10.68 ± 1.63b (REmg/g FW)
    No. Author/References Cultivar Region of growth (Country) Total Polyphenolic Compound mg GAE/g extract Flavonoids (mg/g), Total flavonoids mg CE/g extract
    20 Souleman AMA et al. (2016) [59] PG5 Egypt 53.4 ± 0.32b (GAE mg/g FW) 12.91 ± 0.88a (REmg/g FW)
    21 Zarei M et al. (2010) [63] Aghaye Iran 7.9749 ± 0.110c (mg/gr)
    22 Zarei M et al. (2010) [63] Faroogh Iran 7.2053 ± 0.150 c (mg/gr)
    23 Zarei M et al. (2010) [63] Rabbab-e-Fars Iran 7.8620 ± 0.200 c (mg/gr)
    24 Zarei M et al. (2010) [63] Shahvar Iran 5.2640 ± 0120 c (mg/gr)
    25 Zarei M et al. (2010) [63] Shirin-e-Bihaste) Iran 5.6863 ± 0110 c (mg/gr)
    26 Zarei M et al. (2010) [63] Shirin-e-Mohali Iran 5.6581 ± 0110 c (mg/gr)

     | Show Table
    DownLoad: CSV
    Table 3.  Comparative evaluation of polyphenolic and flavonoid content of seeds of various pomegranate (Punica granatum) cultivars from different regions.
    No. Author/References Cultivar Region of growth (Country) Total Polyphenolic Compound mg GAE/g extract Flavonoids (mg/g), Total flavonoids mg CE/g extract
    1 Gozlekci S et al. (2011) [74] Cekirdeksiz-Ⅳ Turkish 117.0 µg GAE/g fw
    2 Gozlekci S et al. (2011) [74] Katirbasi Turkish 121.2 µg GAE/g fw
    3 Gozlekci S et al. (2011) [74] Lefan Turkish 125.3 µg GAE/g fw
    4 Souleman AMA et al. (2016) [59] PG2 Egypt 95.6 ± 1.17a (GAE mg/g FW) 23.92 ± 1.34a (REmg/g FW)
    5 Gozlekci S et al. (2011) [74] Asinar Turkish 177.4 µg GAE/g fw
    6 Souleman AMA et al. (2016) [59] PG1 Egypt 123.7 ± 1.35 (GAE mg/g FW) 26.45 ± 0.29 (REmg/g FW)
    7 Souleman AMA et al. (2016) [59] PG3 Egypt 109.1 ± 0.68 22.59 ± 1.22 (REmg/g FW)
    8 Souleman AMA et al. (2016) [59] PG4 Egypt 92.8 ± 0.59a (GAE mg/g FW) 24.23 ± 0.95a (REmg/g FW)
    9 Souleman AMA et al. (2016) [59] PG5 Egypt 86.7 ± 1.26 (GAE mg/g FW) 19.84 ± 1.37 (REmg/g FW)

     | Show Table
    DownLoad: CSV

    Owing to the pomegranate health benefits, consumption of fresh pomegranates juice is increasing. Rich bioactive compound cultivars are a significant source of desirable antioxidant properties for health promotion. Pomegranate peel and pulp contain various kinds of antioxidants; however, pomegranate peel had the most antioxidant efficacy compared to the pulp and seed fractions [47].

    The results of a number of investigations on phenolic compounds and antioxidant capacity of eighteen various pomegranate cultivars grown in Morocco revealed that thepolyphenols concentration in pomegranate was high, and antioxidant activity and physico-chemical characteristics in pomegranates were influenced by the type of cultivar. Phenolic compounds of pomegranates are graded on phenolic acids (ellagic acid, gallic acid, chlorogenic acid, caffeic acid, vanillic acid, ferulic acids trans-2- Hydrocinnamic acid, quercetin). Additionally, some flavonoids such as catechin, rutin, quercetin and phloridzin were identified in pomegranate juice at various concentrations among the pomegranate cultivars [48].

    Although pomegranate peels and the other remaining tissues are inedible, it would be possible to use them to prepare new products such as flavonoids capsules and other nutraceuticals after extraction. There are many pomegranate cultivars, which are classified and correlated based on some important parameters such as morphological characteristics of flower and tree.

    Differences in the phenolic compound index among various parts of pomegranate were observed. Pomegranate peels indicated a high concentration of phenolic compounds, and ellagitannins have largest quantities in relation to pomegranate pulp and juice for each cultivar [49]. Owing to meeting the current market demand for fruits quality, the characteristics of pomegranate cultivars are important.

    This paper provides an overview of biology evaluation of the phenolic and flavonoid contents of different pomegranate cultivars.

    This review described a polyphenolic and flavonoid analysis and geographic origins of different pomegranate cultivars.

    Different parts of the pomegranate such as peel can act as potentially antimicrobial agents. Table 1 shows that the Ganesh cultivar possesses the highest polyphenilic compound, indicating an association between polyphenols level and antibacterial activities. Bassiri-Jahromi et al. in their in-vivo investigation indicated that Saveh sour malas Persian cultivar possessed the best activity against 8 Candida strains [16]. Owing to the significant amount of phenolic compounds, Saveh sour malas is one of the best cultivars (Table 1). These findings demonstrated the relationship between the amount of polyphenolic compounds and its anti-candidiasis effect.

    Therefore, it may be suggested as a natural alternative to synthetic antimicrobial agents. Punicalagin content in pomegranate extract is tannin, which is reported to be responsible for antimicrobial activity. Furthermore, the tannin rich bioactive fractions and ellagitannins have antibacterial [50], antifungal [51] and antimalaria properties [52].

    Moreover, polyphenolic compounds not only play a role in controlling various related diseases to oxidative stress [9], but also regulate the activity of various cell receptors and enzymes [53].

    Because the chemical composition of pomegranate peel is differ with the cultivar type such as sweet, sure, and sour-sweet [54,55], pomegranate antimicrobial activity may vary regarding its cultivar [56]. Tehranifar et al. (2010) [57] reported that total polyphenols and tannins content in pomegranate juice were dependent on major chemical factors.

    Kulkarni et al. [58] reported that antioxidant activity growth at the late-developmental phase was due to anthocyanins composition.

    By investigating nine different cultivars, Shams Ardakani indicated that pulp of Sour Summer cultivar as a strong source of original antioxidants had the highest antioxidant activity than other cultivars (p < 0.05). The peel of Sour Summer, Sweet saveh malas, and Black peel is a considerable source of phenolic and flavonoid compound appropriate for phenolic and flavonoid purification and extraction. In addition, they reported that peel extracts had higher potential antioxidant activity and polyphenolic and flavonoid content than the pulps [38]. The pomegranate peel extract antioxidant capacity is 10 times greater than that of the pomegranate pulp extract. The North white peel and Black peel cultivar contain the highest flavonoid. Souleman et al. (2016) reported that seed of Egyptian pomegranate cultivar (PG1) contained the most total phenolic and flavonoids compounds (Table 3) [59].

    Bassiri-Jahromi et al. (2015) [15] indicated that the peel extract of Saveh malas cultivar had the most effective element compared to other cultivars against Candida spp by MIC test [15]. Table 1 indicate that peel of Saveh malas pomegranate cultivar possesses a significant source of polyphenolic and flavonoid content compared to other cultivars. Difference in the pomegranate chemical compound is related to the cultivar, growing region, maturity, cultivation, climate, and storage situation [48]. This difference is also correlated with the latitude, altitude and longitude of growing regions [60]. The anthocyanin level of pomegranate juice variation was attributed to diversities of cultivars and growing region and various maturity levels of the pomegranate [40]. The pomegranate juice color is a significant index for juice quality; it is originally related to anthocyanin concentration.

    Middha et al. [61] reported that higher total flavonoid concentration of pomegranate juice was almost correlated with sweet and sour cultivar and growing area. Although pomegranate anthocyanin pigments concentration decreased during 100 days, a considerable decrease in acidity was found as the significant chemical factor for increased incidence in over-ripe fruits.

    This review clearly indicated that pomegranate peel extract possessed more natural antioxidants and activity as a health supplement than the pomegranate pulp extract. Derakhshani et al. in their study showed that the pomegranate peel extract contained high levels of antioxidant activity compared to seeds and juice in three different cultivars of various regions of Iran [62].

    Table 1 shows the comparative evaluation of phenolic and flavonoids compounds attributes to various peels of pomegranate cultivars grown in the world.

    These diversities may be owing to variety of cultivar, climate, edaphic condition, different maturity level, and particularly tannin specification method. Total tannin concentration pomegranate spectroscopic analyses by Khanavi et al. (2013) [1] in Iran revealed that Black peel cultivar had the most hyperoside content in its pulp and peel. Hyperoside is identified as the significant flavonoid with respect to antioxidant activity. The results indicated that commercial pomegranate juice had significant phenolic quantity and antioxidant capacity. Furthermore, Zarei et al. (2010) revealed a significant difference in total phenolics, tannins, and antioxidant activity in the juice of six different Persian cultivars (Table 2) [63]. The polyphenolic content and antioxidant potent of the whole pomegranate juice were remarkably superior to aril juice of pomegranate from the same cultivar, due to the entrance of phenolic compounds from the rind sections of pomegranate to the juice [64].

    Hajimahmoodi et al. [65] reported that pulp of Sour summer cultivar had the most antioxidant potent among the nine various pomegranate cultivars. The antioxidant capacity of pomegranate peel extract was 10 times higher than the pulp extract.

    The antioxidant activity of pomegranate peels showed a rapid decrease in 20 to 60 days of fruit development (13%) [58]. Furthermore, Kulkarni et al. [58] reported a slight but important decrease in anthocyanin pigment after 100 days (9.3%). Moreover, they concluded that the anthocyanin increasing and phenolics decreasing were correlated with each other. In this regard, phenolics were exhausted when the anthocyanin pigment formation and the phenols were destroyed and their contents reduced [56].

    Mphahlele et al. in their investigation showed that freeze-drying could be a viable method to proceed pomegranate peel to maintain the maximum natural value of their bioactive compounds [66].

    Different pomegranate cultivars had different polyphenol compositions and antioxidant potential. It is considerably associated with many factors such as cultivar type, growing region, maturity, cultivation, climate, edaphic condition, and storage situation [65]. They were also correlated with the latitude, altitude and longitude of growing regions. Additionally, difference in the average temperature and daily temperature during maturity and harvest period had significant effects on the total polyphenols, flavonoids and anthocyanin concentration of pomegranate.

    Further future investigations are necessary to establish a database for pomegranate showing polyphenol and flavonoids compositions, antioxidant activities, physiochemical characteristics and their relation to environmental factors in various growing areas of the world. The data would be useful to produce better crops with higher nutritional quality. This database provides geographic product labeling and pomegranate brand identification.

    This review is based on a method of systematic narrative review on comparative evaluation of bioactive compounds of various pomegranate cultivars. We conducted an extensive search using the PubMed, Web of Science, Science Direct, and Scopus databases in April 2018 to obtain related studies. This review aimed to present an overview of the comparison of the chemical analysis of total phenolic and flavonoids content of various pomegranate cultivars grown in different geographic regions of the world and to shows perspective advantages of pomegranate compound. It also aimed to summarize the present data from in vitro and in vivo tests animal trial systems and human clinical trials concerning the benefit of pomegranate compound. In addition, this review considered the pomegranate peel and pulp extracts activities and their future potential.

    The findings of this review support that the pomegranate might be used in preventing and curing some diseases.

    This study demonstrated considerable differences among the cultivars in most measured factors such as total poly phenolics, flavonoids, antioxidant activity and anthocyanins content. It also highlights the current aspects and the new research into the potential therapeutic pomegranate for some diseases and the future of clinical research of pomegranate.

    We gratefully acknowledge the financial support of the Pasteur Institute of Iran Research Council (project No.TP-9003).

    No author of this paper has a conflict of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included in this manuscript.

    [1] Logrip ML, Segev B, Warnault V, et al. (2015) Corticostriatal BDNF and alcohol addiction. Brain Res 1628: 60-67. doi: 10.1016/j.brainres.2015.03.025
    [2] World Health Organization (2014) Global status report on alcohol and health. Available from: http://www.who.int/substance_abuse/publications/global_alcohol_report/en/
    [3] Cadet JL (2016) Epigenetics of stress, addiction and resilience: therapeutic implications. Mol Neurobiol 53: 545-560. doi: 10.1007/s12035-014-9040-y
    [4] Martinez JM, Garakani A, Yehuda R et al. (2012) Proinflammatory and “resiliency” proteins in the CSF of patients with major depression. Depress Anxiety 29: 32-38. doi: 10.1002/da.20876
    [5] Daskalakis NP, de Kloet E, Yehuda R, et al. (2015) Early life stress effects on glucocorticoid-BDNF interplay in the hippocampus. Front Mol Neurosci 8: 68-80.
    [6] Pang PT, Teng HK, Zaitsev E, et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491. doi: 10.1126/science.1100135
    [7] Revest JM, Le Roux A, Roullot-Lacarriere V, et al. (2014) BDNF-TrkB signaling through Erk1/2 MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids. Mol Psychiatry 19: 1001-1009. doi: 10.1038/mp.2013.134
    [8] Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat Rev Neurosci 4: 299-309. doi: 10.1038/nrn1078
    [9] Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Ann Rev Biochem 72: 609-642. doi: 10.1146/annurev.biochem.72.121801.161629
    [10] Egan MF, Kojima M, Callicott JH (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
    [11] Lu B, Gottschalk W (2000) Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog Brain Res 128: 231-241. doi: 10.1016/S0079-6123(00)28020-5
    [12] Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2: 24-32. doi: 10.1038/35049004
    [13] Koshimizu H, Kiyosue K, Hara T, et al. (2009) Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain 13: 2-27.
    [14] Hosang GM, Shiles C, Tansey KE, et al. (2014) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 12: 7-18. doi: 10.1186/1741-7015-12-7
    [15] Chen ZY, Patel PD, Sant G, et al. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met 66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24: 4401-4411. doi: 10.1523/JNEUROSCI.0348-04.2004
    [16] Czira ME, Wersching H, Baune BT, et al. (2012) Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population. Age (Dordr) 34: 1529-1541. doi: 10.1007/s11357-011-9313-6
    [17] Hong CJ, Liou YJ, Tsai SJ (2011) Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull 86: 287-297. doi: 10.1016/j.brainresbull.2011.08.019
    [18] Cheeran B, Talelli P, Mori F, et al. (2008) A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and response to rTMS. J Physiol 586: 5717-5725. doi: 10.1113/jphysiol.2008.159905
    [19] Lamb YN, McKay NS, Thompson CS, et al. (2015a) Brain-derived neurotrophic factor Val66Met polymorphism, human memory, and synaptic neuroplasticity. Wiley Interdiscip Rev Cogn Sci 6: 97-108.
    [20] Lamb YN, Thompson CS, McKay NS, et al. (2015b) The brain-derived neurotrophic factor (BDNF) val66met polymorphism differentially affects performance on subscales of the Wechsler Memory Scale—Third Edition (WMS-III). Front Psychol 6: 1212-1220.
    [21] Hariri AR, Goldberg TE, Mattay VS, et al. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23: 6690-6694.
    [22] Notaras M, Hill R, van den Buuse M (2015a) The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry 20: 916-930.
    [23] Notaras M, Hill R, van den Buuse M (2015b) A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci Biobehav Rev 51: 15-30.
    [24] Feltenstein MW, See RE (2013) Systems level neuroplasticity in drug addiction. Cold Spring Harb Perspect Med 3: a011916
    [25] Luscher C, Malenka RC (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69: 650-663. doi: 10.1016/j.neuron.2011.01.017
    [26] Nestler EJ (2014) Epigenetic mechanisms of drug addiction. Neuropharmacology 76: 259-268. doi: 10.1016/j.neuropharm.2013.04.004
    [27] Russo SJ, Dietz DM, Dumitriu D, et al. (2011) The addicted synapse: mechanisms of synaptic and structural plasticity in the nucleus accumbens. Trends Neurosci 33: 267-276.
    [28] Moonat S, Pandey SC (2012) Stress, epigenetics, and alcoholism. Alcohol Res 34: 495-505.
    [29] Ghitza UE, Zhai H, Wu P, et al. (2010) Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev 35: 157-171. doi: 10.1016/j.neubiorev.2009.11.009
    [30] Logrip ML, Janak PH, Ron D (2009) Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J Neurochem 109: 1459-1468. doi: 10.1111/j.1471-4159.2009.06073.x
    [31] Darcq E, Warnault V, Phamluong K, et al. (2015) MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption. Mol Psychiatry 20: 1219-1231.
    [32] Jeanblanc J, He D-Y, Carnicella S, et al. (2009) Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 29: 13494-13502. doi: 10.1523/JNEUROSCI.2243-09.2009
    [33] McGough NNH, He D-Y, Logrip ML, et al. (2004) RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 24: 10542-10552. doi: 10.1523/JNEUROSCI.3714-04.2004
    [34] Logrip ML, Janak PH, Ron D (2008) Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB Journal 22: 2393-2404. doi: 10.1096/fj.07-099135
    [35] Vengeliene V, Bilbao A, Molander A, et al. (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154: 299-315.
    [36] Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89: 649-705. doi: 10.1152/physrev.00013.2008
    [37] Breese GR, Criswell HE, Carta M, et al. (2006) Basis of the gabamimetic profile of ethanol. Alcohol Clin Exp Res 30: 731-744. doi: 10.1111/j.0145-6008.2006.00086.x
    [38] Roberto M, Madamba SG, Moore SD, et al. (2003). Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sc. USA 100: 2053-2058. doi: 10.1073/pnas.0437926100
    [39] Silberman Y, Winder DG (2015) Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: an update and future directions. Alcohol 49: 179-184. doi: 10.1016/j.alcohol.2015.01.006
    [40] Gilpin NW, Herman MA, Roberto M (2015) The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry 77: 859-869. doi: 10.1016/j.biopsych.2014.09.008
    [41] Brady KT, Sonne SC (1999) The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health 23: 263-271.
    [42] Sinha R (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology 158: 343-359. doi: 10.1007/s002130100917
    [43] Sinha R (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141: 105-130. doi: 10.1196/annals.1441.030
    [44] Becker HC (2012) Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alc Res 34: 448-458.
    [45] Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149-1159. doi: 10.1176/appi.ajp.2007.05030503
    [46] Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58. doi: 10.1126/science.278.5335.52
    [47] Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
    [48] Vink JM (2016) Genetics of addiction: future focus on gene x environment interaction? J Stud Alcohol Drugs 77: 684-687. doi: 10.15288/jsad.2016.77.684
    [49] Morrow JD, Flagel SB (2016) Neuroscience of resilience and vulnerability for addiction medicine: from genes to behavior. Prog Brain Res 223: 3-18. doi: 10.1016/bs.pbr.2015.09.004
    [50] Pittenger C (2011) Epigenetic modification of the BDNF locus by early-life enrichment: towards a molecular correlate of resilience? Neurosci Lett 495: 165-167. doi: 10.1016/j.neulet.2011.03.041
    [51] Cecil CAM, Walton E, Viding E (2016) Epigenetics of alcoholism: current knowledge, challenges, and future directions. J Stud Alcohol Drugs 77: 688-691. doi: 10.15288/jsad.2016.77.688
    [52] Malter Cohen M, Tottenham N, Casey BJ (2013) Translational developmental studies of stress on brain and behavior: implications for adolescent mental health and illness? Neuroscience 249: 53-62. doi: 10.1016/j.neuroscience.2013.01.023
    [53] Jeanneteau F, Chao MV (2013) Are BDNF and glucocorticoid activities calibrated? Neuroscience 239: 173-195. doi: 10.1016/j.neuroscience.2012.09.017
    [54] Jeanneteau FD, Lambert SM, Ismaili N, et al. (2012) BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci USA 109: 1305-1310. doi: 10.1073/pnas.1114122109
    [55] McEwen BS, Bowles NP, Gray JD, et al. (2015) Mechanisms of stress in the brain. Nat Neurosci 18: 1353-1363. doi: 10.1038/nn.4086
    [56] de Kloet E, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-475.
    [57] Davidson RJ, McEwen BS (2012) Social influences on neuroplasticity: stress and interventions to promote well-being. Nat Neurosci 15: 689-695. doi: 10.1038/nn.3093
    [58] Grassi-Oliveira R, Stein LM, Lopes RP, et al. (2008) Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression – a preliminary report. Biol Psychiatry 64: 281-285. doi: 10.1016/j.biopsych.2008.02.023
    [59] Roth TL, Lubin FD, Funk AJ, et al. (2009) Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65: 760-769. doi: 10.1016/j.biopsych.2008.11.028
    [60] Branchi I, Karpova NN, D’Andrea I, et al. (2011) Epigenetic modifications induced by early enrichment are associated with changes in timing of induction of BDNF expression. Neurosci Lett 495: 168-172. doi: 10.1016/j.neulet.2011.03.038
    [61] Forero DA, Lopez-Leon S, Shin HD, et al. (2015) Meta-analysis of six genes (BDNF, DRD1, DRD3, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence. Drug Alcohol Depend 149: 259-263. doi: 10.1016/j.drugalcdep.2015.01.017
    [62] Haerian BS (2013) BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis. Pharmacogenomics 14: 2055-2065.
    [63] Meng D, Wu T, Rao U, et al. (2011) Serum NPY and BDNF response to a behavioral stressor in alcohol-dependent and healthy control participants. Psychopharmacology 218: 59-67. doi: 10.1007/s00213-011-2414-1
    [64] Karege F, Bondolfi G, Gervasoni N, et al. (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57: 1068-1072. doi: 10.1016/j.biopsych.2005.01.008
    [65] Unternaehrer E, Luers P, Mill J, et al. (2012). Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF) after acute psychosocial stress. Transl Psychiatry 2: e150
    [66] Giese M, Beck J, Brand S (2014) Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. J Psychiatr Res 59: 1-7. doi: 10.1016/j.jpsychires.2014.09.005
    [67] Pan W, Banks WA, Fasold MB, et al. (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561. doi: 10.1016/S0028-3908(98)00141-5
    [68] D’Sa C, Dileone RJ, Anderson GM, et al. (2012) Serum and plasma brain-derived neurotrophic factor (BDNF) in abstinent alcoholics and social drinkers. Alcohol 46: 253-259. doi: 10.1016/j.alcohol.2011.12.001
    [69] Klein AB, Williamson R, Santini MA, et al. (2010) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 7: 1-7.
    [70] Sartorius A, Hellweg R, Litzke J, et al. (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42: 270-276. doi: 10.1055/s-0029-1224162
    [71] Lang UE, Hellweg R, Seifert F, et al. (2007) Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol Psychiatry 62: 530-535. doi: 10.1016/j.biopsych.2007.01.002
    [72] Bus BAA, Molendijk ML, Penninx BJWH, et al. (2011) Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 36: 228-239. doi: 10.1016/j.psyneuen.2010.07.013
    [73] Begliuomini E, Lenzi F, Ninni E, et al. (2008) Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 197: 429-435. doi: 10.1677/JOE-07-0376
    [74] Pluchino N, Cubeddu A, Begliuomini S, et al. (2009) Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod 24: 2303-2309. doi: 10.1093/humrep/dep119
    [75] Choi S-W, Bhang S, Ahn J-H (2011) Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects. Psychiatry Res 186: 427-430. doi: 10.1016/j.psychres.2010.07.028
    [76] Oh H, Lewis DA, Sibille E (2016) The role of BDNF in age-dependent changes of excitatory and inhibitory synaptic markers in the human prefrontal cortex. Neuropsychopharmacology [Epub ahead of print, doi: 10.1038/npp.2016.126].
    [77] Del Boca F, Darkes J (2003) The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 98: 1-12.
    [78] Sobell LC, Sobell MB (1995) Alcohol consumption measures. In: Allen, J.P., Columbus, M. Editors, Assessing Alcohol Problems: A Guide for Clinicians and Researchers, Bethesda, MD: National Institute on Alcohol Abuse & Alcoholism, 55-73.
    [79] Leeman RF, Heilig M, Cunningham CL, et al. (2010) Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol 15: 109-124.
    [80] Thabrew H, de Sylva S, Romans SE (2012) Evaluating childhood adversity. Adv Psychosom Med 32: 35-57.
    [81] Brown GW, Craig TK, Harris TO, et al. (2007) Validity of retrospective measures of early maltreatment and depressive episodes using the childhood experience of care and abuse (ceca) instrument—a life-course study of adult chronic depression-2. J Affect Disord 103: 217-224. doi: 10.1016/j.jad.2007.06.003
    [82] Fergusson DM, Horwood LJ, Woodward LJ (2000) The stability of child abuse reports: a longitudinal study of the reporting behavior of young adults. Psychol Med 30: 529-544. doi: 10.1017/S0033291799002111
    [83] Shin S, Stewart R, Ferri CP, et al. (2010) An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. Int J Geriatr Psychiatry 25: 441-448. doi: 10.1002/gps.2358
    [84] Colzato LS, Van der Does AJ, Kouwenhoven C, et al. (2011) BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 36: 1562-1569. doi: 10.1016/j.psyneuen.2011.04.010
    [85] Su N, Zhang L, Fei F, et al. (2011) The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response. Brain Res 1415: 119-126. doi: 10.1016/j.brainres.2011.08.005
    [86] Cheah SY, Lawford BR, Young RM, et al. (2014) BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia. Alcohol Alcohol 49: 491-497. doi: 10.1093/alcalc/agu040
    [87] Nees F, Witt SH, Dinu-Biringer R, et al. (2015) BDNF Val66Met and reward-related brain function in adolescents: role for early alcohol consumption. Alcohol 49: 103-110.
    [88] Hill SY, Wang S, Carter H, et al. (2011) Cerebellum volume in high-risk offspring from multiplex alcohol dependence families: association with allelic variation in GABRA2 and BDNF. Psychiatry Res 194: 304-313. doi: 10.1016/j.pscychresns.2011.05.006
    [89] Kim SG, Ugurbil K, Strick PL (1994) Activation of a cerebellar output nucleus during cognitive processing. Science 265: 949-951. doi: 10.1126/science.8052851
    [90] Andreasen NC, O’Leary DS, Cizaldo T, et al. (1995) PET studies of memory: novel versus practiced free recall of word lists. Neuroimage 2: 296-305. doi: 10.1006/nimg.1995.1037
    [91] Andreasen NC, O’Leary DS, Arndt S, et al. (1996) Neural substrates of facial recognition. J Neuropsychiatry Clin Neurosci 8: 139-146. doi: 10.1176/jnp.8.2.139
    [92] Andreasen NC, O’Leary DS, Paradiso S, et al. (1999). The cerebellum plays a role in conscious episodic memory retrieval. Hum Brain Mapp 8: 226-234.
    [93] Allen G, Buxton R, Wong E, et al. (1997) Attentional activation of the cerebellum independent of motor involvement. Science 275: 1940-1943. doi: 10.1126/science.275.5308.1940
    [94] Fiez JA, Raichle ME, Miezin FM, et al. (1995) PET studies of auditory and phonological processing: effects of stimulus characteristics and task demands. Trends Cogn Sci 7: 357-375.
    [95] Turner BM, Paradiso S, Marvel C, et al. (2007) The cerebellum and emotional experience. Neuropsychologia 45: 1331-1341. doi: 10.1016/j.neuropsychologia.2006.09.023
    [96] Mon A, Durazzo TC, Gazdzinski S, et al. (2013) Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Genes Brain Behav 12: 98-107. doi: 10.1111/j.1601-183X.2012.00854.x
    [97] Hoefer ME, Pennington DL, Durazzo TC, et al. (2014) Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol 48: 631-638. doi: 10.1016/j.alcohol.2014.08.007
    [98] Pecina M, Martinez-Jauand M, Love T, et al. (2014) Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J Neurosci 34: 5874-5881.
    [99] Chen J, Hutchison KE, Calhoun VD, et al. (2015) CREB-BDNF pathway influences alcohol cue-elicited activation in drinkers. Hum Brain Mapp 36: 3007-3019. doi: 10.1002/hbm.22824
    [100] Claus ED, Ewing SW, Filbey FM, et al. (2011) Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology 36: 2086-2096.
    [101] Liu J, Calhoun VD, Chen J, et al. (2013) Effect of homozygous deletions at 22q13.1 on alcohol dependence severity and cue-elicited BOLD response in the precuneus. Addict Biol 18: 548-558.
    [102] Park MS, Sohn JH, Suk JA, et al. (2007) Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol 42: 417-422. doi: 10.1093/alcalc/agl117
    [103] Schacht JP, Anton RF, Myrick H. (2013) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18: 121-133. doi: 10.1111/j.1369-1600.2012.00464.x
    [104] Tapert SF, Brown GG, Baratta MV, et al. (2004) fMRI BOLD response to alcohol stimuli in alcohol dependent young women. Addict Behav 29: 33-50. doi: 10.1016/j.addbeh.2003.07.003
    [105] Grzywacz A, Samochowiec A, Ciechanowicz A, et al. (2010) Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol Rep 62: 938-941. doi: 10.1016/S1734-1140(10)70354-6
    [106] Muschler MA, Heberlein A, Frieling H, et al. (2011) Brain-derived neurotrophic factor, Val66Met single nucleotide polymorphism is not associated with alcohol dependence. Psychiatr Genet 21: 53-54. doi: 10.1097/YPG.0b013e32834133ab
    [107] Benzerouk F, Gierski F, Gorwood P, et al. (2013) Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol 47: 271-274. doi: 10.1016/j.alcohol.2013.03.001
    [108] Benzerouk F, Gierski F, Raucher-Chene D, et al. (2015) Association study between reward dependence and a functional BDNF polymorphism in adult women offspring of alcohol-dependent probands. Psychiatr Genet 25: 208-211. doi: 10.1097/YPG.0000000000000099
    [109] Nedic G, Perkovic MN, Sviglin KN, et al. (2013) Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes. Prog Neuropsychopharmacol Biol Psychiatry 40: 193-198. doi: 10.1016/j.pnpbp.2012.09.005
    [110] Serretti A, Souery D, Antypa N, et al. (2013) The impact of adverse life events on clinical features and interaction with gene variants in mood disorder patients. Psychopathology 46: 384-389.
    [111] Dalvie S, Stein DJ, Koenen K, et al. (2014) The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14: 328-335.
    [112] Heberlein A, Buscher P, Schuster R, et al. (2015) Do changes in the BDNF promotor methylation indicate the risk of alcohol relapse? Eur Neuropsychopharmacol 25: 1892-1897. doi: 10.1016/j.euroneuro.2015.08.018
    [113] Moore D, (2015) The Developing Genome. Oxford: Oxford University Press.
    [114] Morrow JD, Flagel SB (2016) Neuroscience of resilience and vulnerability for addiction medicine: from genes to behavior.
    [115] Lhullier AC, Moreira FP, da Silva RA, et al. (2015) Increased serum neurotrophin levels related to alcohol use disorder in a young population sample. Alcohol Clin Exp Res 39: 30-33. doi: 10.1111/acer.12592
    [116] Zhang XY, Tan YL, Chen DC, et al. (2016) Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population. Psychopharmacology 233: 435-445. doi: 10.1007/s00213-015-4124-6
    [117] Buchsbaum DG, Buchanan RG, Welsh J, et al. (1992) Screening for drinking disorders in the elderly using the CAGE questionnaire. J Am Geriatr Soc 40: 662-665. doi: 10.1111/j.1532-5415.1992.tb01956.x
    [118] Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127: 1653-1658. doi: 10.1176/ajp.127.12.1653
    [119] Heberlein A, Muschler M, Wilhelm J, et al. (2010) BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 34: 1060-1064. doi: 10.1016/j.pnpbp.2010.05.025
    [120] Costa MA, Girard M, Dalmay F, et al. (2011) Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin Exp Res 35: 1966-1973. doi: 10.1111/j.1530-0277.2011.01548.x
    [121] Zanardini R, Fontana A, Pagano R, et al. (2011) Alterations of brain-derived neurotrophic factor serum levels in patients with alcohol dependence. Alcohol Clin Exp Res 35: 1529-1533.
    [122] Huang MC, Chen CH, Liu HC, et al. (2011) Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res 35: 126-131. doi: 10.1111/j.1530-0277.2010.01329.x
    [123] Kohler S, Klimke S, Hellweg R, et al. (2013) Serum brain-derived neurotrophic factor and nerve growth factor concentrations change after alcohol withdrawal: preliminary data of a case-control comparison. Eur Addict Res 19: 98-104. doi: 10.1159/000342334
    [124] Reynolds PM, Mueller SW, MacLaren R, (2015) A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal. Alcohol 49: 15-19. doi: 10.1016/j.alcohol.2014.11.006
    [125] Kirschbaum C, Pirke KM, Hellhammer DH. (1993) The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28: 76-81.
    [126] Kim JH, Kim SJ, Lee WY, et al. (2013) The effects of alcohol abstinence on BDNF, ghrelin, and leptin secretions in alcohol-dependent patients with glucose tolerance. Alcohol Clin Exp Res 37 Suppl 1: E52-E58.
    [127] Miguez-Burbano MJ, Espinoza L, Whitehead NE, et al. (2014a) Brain-derived neurotrophic factor and cognitive status: the delicate balance among people living with HIV, with and without alcohol abuse. Curr HIV Res 12: 254-264.
    [128] Miguez-Burbano MJ, Espinoza L, Vargas et al. (2014b) Mood disorders and BDNF relationship with alcohol drinking trajectories among PLWH receiving care. J Alcohol Drug Depend 2: 148-165.
    [129] Skinner HA, Horn JL, (1984) Alcohol Dependence Scale (ADS) user’s guide. Toronto: Addiction Research Foundation.
    [130] Parsons OA, Nixon SJ (1993) Neurobehavioral sequelae of alcoholism. Neurol Clin 11: 205-218.
    [131] Neupane SP, Lien L, Ueland T, et al. (2015) Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Alcohol 49: 471-478.
    [132] Heath AC, Lessov-Schlaggar CN, Lian M, et al. (2016) Research on gene-environment interplay in the era of “big data”. J Stud Alcohol Drugs 77: 681-683. doi: 10.15288/jsad.2016.77.681
    [133] Dick DM (2016) The genetics of addiction: where do we go from here? J Stud Alcohol Drugs 77: 673-675. doi: 10.15288/jsad.2016.77.673
    [134] Duncan, L.E., & Keller, M.C. (2011). A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry 168: 1041-1049.
    [135] Srinivasan S, Shariff M, Bartlett SE (2013) The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 4: 1-11.
    [136] Erickson KI, Voss MW, Prakash RS, et al. (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108: 3017-3022. doi: 10.1073/pnas.1015950108
    [137] Disner SG, Beevers CG, Haigh EA, et al. (2011) Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci 12: 467-477. doi: 10.1038/nrn3027
    [138] Clark DA, Beck AT (2010) Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings. Trends Cogn Sci 14: 418-424. doi: 10.1016/j.tics.2010.06.007
    [139] Lutz A, Slagter HA, Dunne JD, et al. (2008) Attention regulation and monitoring in meditation. Trends Cogn Sci 12: 163-169. doi: 10.1016/j.tics.2008.01.005
    [140] Morris T (2016) Developing the catecholamines hypothesis for the acute exercise-cognition interaction in humans: lessons from animal studies. Physiol Behav 165: 291-299. doi: 10.1016/j.physbeh.2016.08.011
  • This article has been cited by:

    1. G. Ausias, G. Dolo, D. Cartié, F. Challois, P. Joyot, J. Férec, Modeling and Numerical Simulation of Laminated Thermoplastic Composites Manufactured by Laser-Assisted Automatic Tape Placement, 2020, 35, 0930-777X, 471, 10.3139/217.3976
    2. Angel Leon, Marta Perez, Anaïs Barasinski, Emmanuelle Abisset-Chavanne, Brigitte Defoort, Francisco Chinesta, Multi-Scale Modeling and Simulation of Thermoplastic Automated Tape Placement: Effects of Metallic Particles Reinforcement on Part Consolidation, 2019, 9, 2079-4991, 695, 10.3390/nano9050695
    3. Chady Ghnatios, Pavel Simacek, Francisco Chinesta, Suresh Advani, A non-local void dynamics modeling and simulation using the Proper Generalized Decomposition, 2020, 13, 1960-6206, 533, 10.1007/s12289-019-01490-7
    4. Tarek Frahi, Clara Argerich, Minyoung Yun, Antonio Falco, Anais Barasinski, Francisco Chinesta, Tape surfaces characterization with persistence images, 2020, 7, 2372-0484, 364, 10.3934/matersci.2020.4.364
    5. Aleksandr N. Anoshkin, Yulia S. Pristupova, Pavel V. Pisarev, Gleb S. Shipunov, 2020, 2216, 0094-243X, 040014, 10.1063/5.0004086
    6. Tarek Frahi, Clara Argerich, Minyoung Yun, Antonio Falco, Anais Barasinski, Francisco Chinesta, Tape surfaces characterization with persistence images, 2020, 7, 2372-0484, 364, 10.3934/ms.2020.4.364
    7. Antoine Runacher, Mohammad-Javad Kazemzadeh-Parsi, Daniele Di Lorenzo, Victor Champaney, Nicolas Hascoet, Amine Ammar, Francisco Chinesta, Describing and Modeling Rough Composites’ Surfaces by Using Topological Data Analysis and Fractional Brownian Motion, 2023, 15, 2073-4360, 1449, 10.3390/polym15061449
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(10947) PDF downloads(1338) Cited by(11)

Figures and Tables

Figures(1)  /  Tables(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog